1. LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer
   Saki Matsui et al, 2017, Oncology Letters CrossRef
2. 17‐AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway
   Xiang‐Yun Ye et al, 2015, Journal of Cellular and Molecular Medicine CrossRef
3. Contribution of LATS1 and LATS2 promoter methylation in OSCC development
   Mohammad Ayoub Rigi Ladiz et al, 2017, Journal of Cell Communication and Signaling CrossRef
4. The NDR/LATS protein kinases in immunology and cancer biology
   Ahmad A.D. Sharif et al, 2018, Seminars in Cancer Biology CrossRef
5. Evaluation ofLATS1andLATS2Promoter Methylation with the Risk of Pterygium Formation
   Maryam Najafi et al, 2016, Journal of Ophthalmology CrossRef
6. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
   Noa Furth et al, 2017, Cell Death & Differentiation CrossRef
7. m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression
   Heng Zhang et al, 2022, Cell Death & Disease CrossRef
8. Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer
   Xu-Yong Lin et al, 2014, Tumor Biology CrossRef
9. Targeting the Hippo Pathway to Improve Response to Chemotherapy
   Yulei Zhao et al, 2019, Targeting Cell Survival Pathways to Enhance Response to Chemotherapy CrossRef
10. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome
    Agnieszka Rybarczyk et al, 2017, Oncology Reports CrossRef
11. Long Noncoding RNA PVT1 Promotes Non–Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression
    Li Wan et al, 2016, Molecular Cancer Therapeutics CrossRef
12. The Hippo pathway in chemotherapeutic drug resistance
    Yulei Zhao et al, 2015, International Journal of Cancer CrossRef
13. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma
    Showkat A. Malik et al, 2018, Pathology & Oncology Research CrossRef
14. Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India
    null Sadaf et al, 2018, Gene CrossRef
15. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas
    Susan Y. Luo et al, 2014, Lung Cancer CrossRef
16. Dysregulation of the Hippo pathway signaling in aging and cancer
    Yiu To Yeung et al, 2019, Pharmacological Research CrossRef